|
A more recent version of this article appeared on April 27, 2001
Papers In Press, published online ahead of print February 8, 2001
J. Biol. Chem, 10.1074/jbc.M008001200
Submitted on August 31, 2000
Revised on February 7, 2001
Accepted on February 8, 2001
A full biological response to autoantibodies in Graves' disease requires a disulfide-bonded loop in the thyrotropin receptor N-terminus homologous to a laminin EGF-like domain
Chun-Rong Chen, Kunihiko Tanaka, Gregorio D. Chazenbalk, Sandra M. McLachlan, and Basil Rapoport
Autoimmune Disease Unit, Cedars-Sinai Medical Center, Los Angeles, CA 90048
Corresponding Author: rapoportb{at}cshs.org
We observed amino acid homology between the cysteine-rich N-terminus of the thyrotropin receptor (TSHR) ectodomain and EGF-like repeats in the laminin g1 chain. Thyroid stimulating autoantibodies (TSAb), the cause of Graves' disease, interact with this region of the TSHR in a manner critically dependent on antigen conformation. We studied the role of the cluster of four cysteine (C) residues in this region of the TSHR on the functional response to TSAb in Graves' patients' sera. As a benchmark we also studied TSH binding and action. Removal in various permutations of the four cysteines at TSHR positions 24, 29, 31 and 41 (signal peptide residues are 1-21), revealed C41 to be the key residue for receptor expression. Forced pairing of C41 with any one of the three upstream C residues was necessary for trafficking to the cell surface of a TSHR with high affinity TSH binding similar to the wild-type receptor. However, for a full biological response to TSAb, forced pairing of C41 with C29 or with C31, but not with C24, retained functional activity comparable to the wild-type TSHR. These data suggest that an N-terminal disulfide-bonded loop between C41 and C29 or its close neighbor C31 comprises, in part, the highly conformational epitope for TSAB at the critical N-terminus of the TSHR. Amino acid homology, as well as cysteine pairing similar to the laminin g1 chain EGF-like repeat 11, suggest conformational similarity between the two molecules and raise the possibility of molecular mimicry in the pathogenesis of Graves' disease.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. Ben-Shlomo, O. Pichurin, N. J. Barshop, K. A. Wawrowsky, J. Taylor, M. D. Culler, V. Chesnokova, N.-A. Liu, and S. Melmed
Selective Regulation of Somatostatin Receptor Subtype Signaling: Evidence for Constitutive Receptor Activation
Mol. Endocrinol.,
October 1, 2007;
21(10):
2565 - 2578.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.-R. Chen, S. M. McLachlan, and B. Rapoport
Suppression of Thyrotropin Receptor Constitutive Activity by a Monoclonal Antibody with Inverse Agonist Activity
Endocrinology,
May 1, 2007;
148(5):
2375 - 2382.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.-C. Ho, S.-S. Goh, I. H C Kee, P. K H Chow, C.-P. Yeo, and D. H C Khoo
Effects of genetic immunization of Swiss outbred mice with human thyroid stimulating hormone receptor cDNA plasmids harboring gain-of-function mutations
J. Mol. Endocrinol.,
February 1, 2007;
38(2):
277 - 288.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. McLachlan, Y. Nagayama, and B. Rapoport
Insight into Graves' Hyperthyroidism from Animal Models
Endocr. Rev.,
October 1, 2005;
26(6):
800 - 832.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Ben-Shlomo, K. A. Wawrowsky, I. Proekt, N. M. Wolkenfeld, S.-G. Ren, J. Taylor, M. D. Culler, and S. Melmed
Somatostatin Receptor Type 5 Modulates Somatostatin Receptor Type 2 Regulation of Adrenocorticotropin Secretion
J. Biol. Chem.,
June 24, 2005;
280(25):
24011 - 24021.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. N. Pichurin, G. D. Chazenbalk, H. Aliesky, O. Pichurina, B. Rapoport, and S. M. McLachlan
"Hijacking" the Thyrotropin Receptor: A Chimeric Receptor-Lysosome Associated Membrane Protein Enhances Deoxyribonucleic Acid Vaccination and Induces Graves' Hyperthyroidism
Endocrinology,
December 1, 2004;
145(12):
5504 - 5514.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Latrofa, G. D. Chazenbalk, P. Pichurin, C.-R. Chen, S. M. McLachlan, and B. Rapoport
Affinity-Enrichment of Thyrotropin Receptor Autoantibodies from Graves' Patients and Normal Individuals Provides Insight into Their Properties and Possible Origin from Natural Antibodies
J. Clin. Endocrinol. Metab.,
September 1, 2004;
89(9):
4734 - 4745.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. D. Chazenbalk, F. Latrofa, S. M. McLachlan, and B. Rapoport
Thyroid Stimulation Does Not Require Antibodies with Identical Epitopes But Does Involve Recognition of a Critical Conformation at the N Terminus of the Thyrotropin Receptor A-Subunit
J. Clin. Endocrinol. Metab.,
April 1, 2004;
89(4):
1788 - 1793.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Muehlberg, J. A. Gilbert, P. V. Rao, A. M. McGregor, and J. P. Banga
Dynamics of Thyroid-Stimulating and -Blocking Antibodies to the Thyrotropin Receptor in a Murine Model of Graves' Disease
Endocrinology,
April 1, 2004;
145(4):
1539 - 1545.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Schwarz-Lauer, P. N. Pichurin, C.-R. Chen, Y. Nagayama, C. Paras, J. C. Morris, B. Rapoport, and S. M. McLachlan
The Cysteine-Rich Amino Terminus of the Thyrotropin Receptor Is the Immunodominant Linear Antibody Epitope in Mice Immunized Using Naked Deoxyribonucleic Acid or Adenovirus Vectors
Endocrinology,
May 1, 2003;
144(5):
1718 - 1725.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Alberti, M. C. Proverbio, S. Costagliola, R. Romoli, B. Boldrighini, M. C. Vigone, G. Weber, G. Chiumello, P. Beck-Peccoz, and L. Persani
Germline Mutations of TSH Receptor Gene as Cause of Nonautoimmune Subclinical Hypothyroidism
J. Clin. Endocrinol. Metab.,
June 1, 2002;
87(6):
2549 - 2555.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Kalafatis, P. Simioni, D. Tormene, D. O. Beck, S. Luni, and A. Girolami
Isolation and characterization of an antifactor V antibody causing activated protein C resistance from a patient with severe thrombotic manifestations
Blood,
May 13, 2002;
99(11):
3985 - 3992.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. W. Szkudlinski, V. Fremont, C. Ronin, and B. D. Weintraub
Thyroid-Stimulating Hormone and Thyroid-Stimulating Hormone Receptor Structure-Function Relationships
Physiol Rev,
April 1, 2002;
82(2):
473 - 502.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|